Over the past decade, fluid biomarkers have transformed the conceptual and clinical framework of neurodegenerative diseases. In Alzheimer’s disease (AD), ...
Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.
Brain-derived extracellular vesicle (EV) biomarkers represent a promising frontier for liquid biopsy development targeting the nervous system. They offer strong potential for enabling minimally ...
OTTAWA, Ontario — Looking for Alzheimer’s disease (AD) biomarkers in plasma instead of cerebrospinal fluid (CSF) is a simpler form of screening individuals for AD pathology and could result in earlier ...
With few biomarkers for early identification and limited therapy options for conditions such as Alzheimer's disease (AD) and Parkinson's disease (PD), there is an urgent need for further information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results